Skip to main content

Table 2 Details of the chemotherapy schedule and doses used for stage T3-4 N0 nasopharyngeal carcinoma patients.

From: Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system

Mode of treatment

Number of patients

%

RT alone

6

17.6

CCRT

7

20.5

NAC + RT

2

5.9

NAC + CCRT

16

47.1

NAC + CCRT + ADC

3

8.8

  1. CCRT, concomitant chemo-radiotherapy (cisplatin, 80 mg/m2 on day 1, 22 and 43 or 40 mg/m2 weekly); NAC, neoadjuvant chemotherapy (cisplatin, 80 mg/m2 day 1; 5-flourouracil, 800 mg/m2 days 1-5); RT, radiotherapy; ADC, adjuvant chemotherapy (cisplatin, 80 mg/m2 day 1; 5-flourouracil, 800 mg/m2 days 1-5).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us